Business Context and Reporting Period
This Form 8-K Current Report was filed by SANUWAVE Health, Inc. on September 3, 2013. The filing reports a corporate governance event involving the election of a new director to the Company's board.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Alan L. Rubino to the Board of Directors on September 3, 2013. His term is set to expire at the 2014 annual meeting of shareholders, with plans to nominate him for re-election.
Guidance, Outlook, and Compensation
In connection with his election, Mr. Rubino was granted a stock option under the Amended and Restated 2006 Stock Incentive Plan. The key terms of this compensatory arrangement are:
- Shares: 100,000 shares of common stock.
- Exercise Price: $0.65 per share.
- Vesting: Fully vested upon issuance.
- Expiration: September 3, 2023.
The filing states there are no other arrangements or understandings regarding Mr. Rubino's selection. No forward-looking guidance or risk factors were disclosed in this specific report.
Investor Verification Checklist
- Verify the total number of outstanding shares to assess the dilution impact of the 100,000 new options.
- Confirm the current market price of the stock relative to the $0.65 exercise price.
- Review the Company's 2006 Stock Incentive Plan to ensure the grant was within authorized limits.
- Check the date of the referenced Press Release (Exhibit 99.1) for additional context on the appointment.